Literature DB >> 20414613

[The hospitalization and the process of becoming ill through the children's and adolescents' perspective with cystic fibrosis and osteogenesis imperfecta].

Daniele Borges de Mello1, Martha Cristina Nunes Moreira.   

Abstract

The present article intends to discuss the results of a study completed in a hospital located in the municipal district of Rio de Janeiro, considered most prominent for child, adolescent and woman's health. We analyzed the meanings of hospitalization and chronic illness in childhood and adolescence through the perspective of children and adolescents with cystic fibrosis and osteogenesis imperfecta during their hospitalizations in order to explore their experience and communicative possibilities as knowledgeable informants. Hence, we privileged the observation and the construction of their productions through games, using drawings and/or story-telling as a relevant approach to childhood and adolescence contents. The data collected signify the acquisition and knowledge production capacity of children and adolescents concerning their illness processes.

Entities:  

Mesh:

Year:  2010        PMID: 20414613     DOI: 10.1590/S1413-81232010000200022

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

Review 1.  The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review.

Authors:  Argerie Tsimicalis; Gabrielle Denis-Larocque; Alisha Michalovic; Carolann Lepage; Karl Williams; Tian-Ran Yao; Telma Palomo; Noemi Dahan-Oliel; Sylvie Le May; Frank Rauch
Journal:  Qual Life Res       Date:  2016-02-19       Impact factor: 4.147

2.  Health-related quality of life of children and adolescents with osteogenesis imperfecta: a cross-sectional study using PedsQL™.

Authors:  Ana Paula Vanz; Juliana van de Sande Lee; Bruna Pinheiro; Marina Zambrano; Evelise Brizola; Neusa Sicca da Rocha; Ida Vanessa D Schwartz; Maria Marlene de Souza Pires; Têmis Maria Félix
Journal:  BMC Pediatr       Date:  2018-03-02       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.